GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » Total Long-Term Liabilities

Concord Biotech (BOM:543960) Total Long-Term Liabilities : ₹319 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Concord Biotech's Total Long-Term Liabilities for the quarter that ended in Mar. 2024 was ₹319 Mil.

Concord Biotech Total Long-Term Liabilities Historical Data

The historical data trend for Concord Biotech's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech Total Long-Term Liabilities Chart

Concord Biotech Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Total Long-Term Liabilities
551.86 774.34 544.04 321.37 319.08

Concord Biotech Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24
Total Long-Term Liabilities Get a 7-Day Free Trial 544.04 - 321.37 292.70 319.08

Concord Biotech Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Concord Biotech Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Concord Biotech's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Biotech (BOM:543960) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » Total Long-Term Liabilities
Comparable Companies
BOM:540701 BOM:543434 NSE:ZOTA BOM:531349 NSE:BALAXI BOM:500259 BOM:524717 BOM:532890 BOM:540679 BOM:524663 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
CONCORDBIO:India
Address
Iscon Cross Road, S.G. Highway, 16th floor, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015
Website
https://www.concordbiotech.com
Concord Biotech Ltd is a Research & development-driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations.

Concord Biotech (BOM:543960) Headlines

No Headlines